Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F-Reference-Cited by-同舟云学术

Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F

Published:2019-02-15 Issue:4 Volume:30 Page:1077-1086
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Daum Steffen¹,Toms Johannes²,Reshetnikov Viktor¹,Özkan Hülya Gizem¹,Hampel Frank¹,Maschauer Simone²,Hakimioun Amir³,Beierlein Frank³,Sellner Leopold⁴,Schmitt Michael⁴,Prante Olaf²^ORCID,Mokhir Andriy¹^ORCID

Affiliation:

1. Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Chemistry and Pharmacy, Organic Chemistry Chair II, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany

2. Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Schwabachanlage 6, 91054 Erlangen, Germany

3. Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Chemistry and Pharmacy, Computer-Chemistry-Center and Interdisciplinary Center for Molecular Materials, Nägelsbachstr. 25, 91052 Erlangen, Germany

4. University Hospital Heidelberg, Department of Medicine V, 69120 Heidelberg, Germany

Funder

Friedrich-Alexander-Universit?t Erlangen-N?rnberg

Deutsche Forschungsgemeinschaft

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.9b00019

Reference37 articles.

1. A review of monoclonal antibody therapies in lymphoma